Podcast: Play in new window | Download (Duration: 41:12 — 45.4MB)
Subscribe: Apple Podcasts | Spotify | RSS
On this episode of Biotalk, Locust Walk welcomes Andrew Allen, M.D., Ph.D., Co-Founder, President, CEO, and board member of Gritstone […]
RNA Therapeutics Landscape Overview Locust Walk views RNA therapeutics in 5 key pillars: RNA Translation Inhibition Protein Expression RNA-Targeting Small
RNA Therapeutics Landscape Overview Locust Walk views RNA therapeutics in 5 key pillars: RNA Translation Inhibition Protein Expression RNA-Targeting Small
Podcast: Play in new window | Download (Duration: 13:12 — 14.7MB)
Subscribe: Apple Podcasts | Spotify | RSS
Our first Biotalk podcast is focused on Locust Walk’s 2022 year-in-review market conditions, which was released the first day of JPMorgan
2022 Year In Review Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and
2022 Q3 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk’s deal team compiles key statistics and trends on
2022 Q2 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk deal team members compile key statistics and trends on
2022 Q1 Report: Global Trends in Biopharma Transactions Each quarter, Locust Walk deal team members compile key statistics and trends
Locust Walk Breakthrough Innovation Reports: Oncology IPS-Effector Cell Therapies In this report you can find an overview and analysis of
Breakthrough Innovation Reports: Regenerative Medicine iPS-Cell Therapy Investment Insights and Emerging Players In this report you can find an overview